Compare BioNTech SE - ADR (BNTX) vs Capital One Financial Corp. (COF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Capital One Financial Corp. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Capital One Financial Corp. trades at $219.35 (market cap $134.45B). The key difference: Capital One Financial Corp. is far larger — about 5.8× BioNTech SE - ADR's market cap, and Capital One Financial Corp. pays a 1.46% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | COF | |
|---|---|---|
Market Cap | $23.31B | $134.45B |
Sector | Health | Financials |
52-Week High | $119.34 | $257.94 |
52-Week Low | $83.89 | $176.10 |
Enterprise Value | $6.60B | — |
Dividend Yield | — | 1.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Capital One Financial Corp.
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
Read more on COF →
